Reuters logo
BRIEF-Genmab announces new Phase III combination study of Daratumumab
April 28, 2017 / 1:35 PM / 7 months ago

BRIEF-Genmab announces new Phase III combination study of Daratumumab

April 28 (Reuters) - GENMAB A/S

* GENMAB ANNOUNCES NEW PHASE III COMBINATION STUDY OF DARATUMUMAB IN MULTIPLE MYELOMA

* STUDY EXPECTED TO START Q2 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below